Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses
暂无分享,去创建一个
Yoshikazu Nakamura | S. Sugiyama | T. Nagata | M. Katahira | T. Kozu | Y. Nomura | Yoichiro Tanaka | Ryotaro Amano | T. Sakamoto | K. Takada
[1] Yoshikazu Nakamura,et al. Conjugation of two RNA aptamers improves binding affinity to AML1 Runt domain , 2017, Journal of biochemistry.
[2] Gota Kawai,et al. NMR monitoring of the SELEX process to confirm enrichment of structured RNA , 2017, Scientific Reports.
[3] Yoshikazu Nakamura,et al. Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein. , 2016, Biochemistry.
[4] John C. Burnett,et al. High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency , 2016, Scientific Reports.
[5] Abhishek Parashar,et al. Aptamers in Therapeutics. , 2016, Journal of clinical and diagnostic research : JCDR.
[6] P. Andreasen,et al. Expected and unexpected features of protein‐binding RNA aptamers , 2016, Wiley interdisciplinary reviews. RNA.
[7] N. Janjić,et al. Embracing proteins: structural themes in aptamer-protein complexes. , 2016, Current opinion in structural biology.
[8] T. Mészáros,et al. Is less more? Lessons from aptamer selection strategies. , 2014, Journal of pharmaceutical and biomedical analysis.
[9] Yoshikazu Nakamura,et al. Solution structure of a DNA mimicking motif of an RNA aptamer against transcription factor AML1 Runt domain. , 2013, Journal of biochemistry.
[10] Yoshikazu Nakamura,et al. The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element , 2013, RNA.
[11] Yoshikazu Nakamura,et al. RNA plasticity and selectivity applicable to therapeutics and novel biosensor development , 2012, Genes to cells : devoted to molecular & cellular mechanisms.
[12] H. Schwalbe,et al. High-resolution NMR structure of an RNA model system: the 14-mer cUUCGg tetraloop hairpin RNA , 2009, Nucleic acids research.
[13] Stuart E. Knowling,et al. Characterization of RNA aptamers that disrupt the RUNX1–CBFβ/DNA complex , 2009, Nucleic Acids Research.
[14] D. Littman,et al. RUNX proteins in transcription factor networks that regulate T-cell lineage choice , 2009, Nature Reviews Immunology.
[15] S. Butcher,et al. DNA mimicry by a high-affinity anti-NF-κB RNA aptamer , 2007, Nucleic acids research.
[16] R. Stoltenburg,et al. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.
[17] B. Sullenger,et al. Gene therapy progress and prospects: RNA aptamers , 2007, Gene Therapy.
[18] F. Mikhail,et al. Normal and transforming functions of RUNX1: A perspective , 2006, Journal of cellular physiology.
[19] N. Speck,et al. Core-binding factors in hematopoiesis and immune function , 2004, Oncogene.
[20] G. Ghosh,et al. Molecular mimicry of the NF-κB DNA target site by a selected RNA aptamer , 2004 .
[21] Jeff Zimmerman,et al. Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] U. Sauer,et al. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding. , 2002, Journal of molecular biology.
[23] N. Speck. Core binding factor and its role in normal hematopoietic development. , 2001, Current opinion in hematology.
[24] Jerónimo Bravo,et al. The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp , 2001, Nature Structural Biology.
[25] Takashi Kumasaka,et al. Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβ , 2001, Cell.
[26] B. Chait,et al. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain , 2000, Nature Structural Biology.
[27] S. Minucci,et al. Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.
[28] G. Varani,et al. Structure of the P1 helix from group I self-splicing introns. , 1995, Journal of molecular biology.
[29] H. Wolfson,et al. Shape complementarity at protein–protein interfaces , 1994, Biopolymers.
[30] M. Lawrence,et al. Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.
[31] M. Ohki,et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[33] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[34] L. Kay,et al. Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins , 1990 .
[35] Pierre Plateau,et al. Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .
[36] M. Ohki,et al. t ( 8 ; 21 ) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene , AMLJ ( chromosomal translocation / cancer genetics , 2022 .